Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV oxytocin after fetal expulsion for management of third stage of labor after second trimester medical termination
2016-003143-11Phase 4Completed
- Sponsor
- Centre Hospitalier Universitaire de Bordeaux
- Start
- Aug 2016
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 4, randomised trial of oxytocin in abortion (2 arms), sponsored by Centre Hospitalier Universitaire de Bordeaux. Primary endpoints: Incidence of placental retention at 30 minutes and Complete placental retention and need for artificial delivery. Started Aug 2016; status: completed.
02
Drugs
oxytocin
03
Conditions
abortion
Beyond the preview
Go deeper on 2016-003143-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-003143-11.